A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Preserved Ejection Fraction

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 305 participants.

Also called NCT03098979

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 305 participants (enrolled count) (from the registry)
Sponsor
  • Bayer Registry lists this organization as the lead sponsor
Registry
  • NCT NCT03098979
  • EudraCT 2016-004062-26
Other papers using this trial's data
  • Effect of Neladenoson Bialanate on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial JAMA, 2019-06-04 DOI, PubMed 31162568, PMC6549300 Not in the PMC Open Access subset.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Austria, Belgium, Bulgaria, Germany, Greece, Israel, Italy, Japan, Poland, Portugal, Spain (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03098979. Randomized; quadruple masking; primary purpose treatment. Start 2017-05-10 (actual); primary completion 2018-05-23 (actual). Results posted on 2019-07-23.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Preserved Ejection Fraction
Acronym
PANACHE
Condition
Heart Failure
Intervention (Drug)
Neladenoson bialanate (BAY1067197)
Intervention (Drug)
Neladenoson bialanate (BAY1067197)
Intervention (Drug)
Neladenoson bialanate (BAY1067197)
Intervention (Drug)
Neladenoson bialanate (BAY1067197)
Intervention (Drug)
Neladenoson bialanate (BAY1067197)
Intervention (Drug)
Placebo
Lead sponsor
Bayer (class: industry)

Record details

Record id
cardio:ct-nct03098979
Content hash
9ed87c2a8f9138a1ca604af75ae2b5caff60d150bc102e349b134522a5722be4